Related Experiment Video
Updated: Jan 10, 2026

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
Published on: May 8, 2017
Correlation between serum ANKRD22 and SERPING1 levels and drug resistance in pulmonary tuberculosis: A retrospective
Qianyun Zhou1, Li Zhang1, Mei Zhou1
1Department of Respiratory and Critical Care Medicine, The People's Hospital of Yubei District of Chongqing, Chongqing, China.
Abstract:
Drug-resistant tuberculosis (TB) lacks rapid blood-based biomarkers. This study examined whether serum levels of ankyrin repeat domain 22 (ANKRD22) and serpin family G member 1 (SERPING1) are associated with drug resistance in TB patients. In this retrospective cross-sectional study, 170 culture-confirmed TB patients treated from January 2023 to December 2023 were classified as drug-resistant (n = 34) or drug-susceptible (n = 136) by phenotypic drug susceptibility testing. We quantified serum ANKRD22 and SERPING1 levels by enzyme-linked immunosorbent assay, used multivariate logistic regression to identify independent risk factors, and assessed diagnostic performance with receiver operating characteristic curve analysis. Both biomarkers were significantly higher in the drug-resistant group (P < .001) and positively correlated with resistance (ANKRD22 R = 0.551, SERPING1 R = 0.520). Area under the curve values were 0.898 for ANKRD22, 0.875 for SERPING1, and 0.912 for combined detection. After adjustment, elevated ANKRD22 and SERPING1 remained independent predictors, along with smoking, chronic obstructive pulmonary disease, cavitary disease, previous TB exposure, and treatment interruption. Serum ANKRD22 and SERPING1 are independently associated with TB drug resistance; their combined measurement improves diagnostic accuracy and may facilitate early detection of drug-resistant TB.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

